Suven Pharmaceuticals Limited (SUVENPHAR.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 270.32B |
| Enterprise Value | 272.26B |
| P/E Ratio | 60.04 |
| PEG Ratio | -1.68 |
| Price/Sales Ratio | 6.83 |
| Price/Book Ratio | 3.97 |
| Enterprise/Revenue | 6.98 |
| Enterprise/EBITDA | 39.63 |
Fiscal Year
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 11.98B |
| Revenue/Share | 59.18 |
| Gross Profit | 8.92B |
| EBITDA | 4.34B |
| Net Income | 2.65B |
| Diluted EPS | 10.45 |
Balance Sheet
| Total Cash | 2.8B |
| Total Cash/Share | 8.5 |
| Total Debt | 0 |
| Total Debt/Equity | 0.1 |
| Current Ratio | 2.78 |
| Book Value Per Share | 105.23 |
Price History
| 52-Week Change | 44.03 |
| 52-Week High | 1,360 |
| 52-Week Low | 598 |
| Moving Average 50 Days | 1,130.01 |
| Moving Average 200 Days | 1,155.58 |
Statistics
| Average Volume | 295,426 |
| Shares Outstanding | 382.57M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | September 25, 2020 |
AD
